Targeted-Delivery of Chemotherapy (NANOLEUK) Vs Standard Chemotherapy in Acute Myeloid Leukemia: A Proposed Randomized, Double-Blinded, Multicenter Efficacy Trial. PPCR 2016, 2 (2).